BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20535211)

  • 1. Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome.
    Reynolds LE; Watson AR; Baker M; Jones TA; D'Amico G; Robinson SD; Joffre C; Garrido-Urbani S; Rodriguez-Manzaneque JC; Martino-Echarri E; Aurrand-Lions M; Sheer D; Dagna-Bricarelli F; Nizetic D; McCabe CJ; Turnell AS; Kermorgant S; Imhof BA; Adams R; Fisher EM; Tybulewicz VL; Hart IR; Hodivala-Dilke KM
    Nature; 2010 Jun; 465(7299):813-7. PubMed ID: 20535211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome.
    Sussan TE; Yang A; Li F; Ostrowski MC; Reeves RH
    Nature; 2008 Jan; 451(7174):73-5. PubMed ID: 18172498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.
    Baek KH; Zaslavsky A; Lynch RC; Britt C; Okada Y; Siarey RJ; Lensch MW; Park IH; Yoon SS; Minami T; Korenberg JR; Folkman J; Daley GQ; Aird WC; Galdzicki Z; Ryeom S
    Nature; 2009 Jun; 459(7250):1126-30. PubMed ID: 19458618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down's syndrome: paradox of a tumour repressor.
    Threadgill DW
    Nature; 2008 Jan; 451(7174):21-2. PubMed ID: 18172483
    [No Abstract]   [Full Text] [Related]  

  • 5. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
    Shin J; Lee JC; Baek KH
    Cancer Lett; 2014 Jan; 342(1):70-81. PubMed ID: 24051307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down's syndrome-like cardiac developmental defects in embryos of the transchromosomic Tc1 mouse.
    Dunlevy L; Bennett M; Slender A; Lana-Elola E; Tybulewicz VL; Fisher EM; Mohun T
    Cardiovasc Res; 2010 Nov; 88(2):287-95. PubMed ID: 20558441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of stromal JUNB does not affect tumor growth and angiogenesis.
    Braun J; Strittmatter K; Nübel T; Komljenovic D; Sator-Schmitt M; Bäuerle T; Angel P; Schorpp-Kistner M
    Int J Cancer; 2014 Mar; 134(6):1511-6. PubMed ID: 24027048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired tumor growth and angiogenesis in mice heterozygous for Vegfr2 (Flk1).
    Oladipupo SS; Kabir AU; Smith C; Choi K; Ornitz DM
    Sci Rep; 2018 Oct; 8(1):14724. PubMed ID: 30283071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis.
    Hou S; Niu G; Liu X; Bourbon PM; Zhang D; Cui P; Zhao K; Zhao D; Zeng H
    Microvasc Res; 2021 Nov; 138():104209. PubMed ID: 34146582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis in Down's syndrome: lessons from studies of human and mouse models.
    Rueda N; Flórez J; Martínez-Cué C
    Apoptosis; 2013 Feb; 18(2):121-34. PubMed ID: 23224708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain.
    Ahmed MM; Dhanasekaran AR; Tong S; Wiseman FK; Fisher EM; Tybulewicz VL; Gardiner KJ
    Hum Mol Genet; 2013 May; 22(9):1709-24. PubMed ID: 23349361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome.
    Gribble SM; Wiseman FK; Clayton S; Prigmore E; Langley E; Yang F; Maguire S; Fu B; Rajan D; Sheppard O; Scott C; Hauser H; Stephens PJ; Stebbings LA; Ng BL; Fitzgerald T; Quail MA; Banerjee R; Rothkamm K; Tybulewicz VL; Fisher EM; Carter NP
    PLoS One; 2013; 8(4):e60482. PubMed ID: 23596509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic ablation of the alpha 6-integrin subunit in Tie1Cre mice enhances tumour angiogenesis.
    Germain M; De Arcangelis A; Robinson SD; Baker M; Tavora B; D'Amico G; Silva R; Kostourou V; Reynolds LE; Watson A; Jones JL; Georges-Labouesse E; Hodivala-Dilke K
    J Pathol; 2010 Feb; 220(3):370-81. PubMed ID: 19967723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.
    Arron JR; Winslow MM; Polleri A; Chang CP; Wu H; Gao X; Neilson JR; Chen L; Heit JJ; Kim SK; Yamasaki N; Miyakawa T; Francke U; Graef IA; Crabtree GR
    Nature; 2006 Jun; 441(7093):595-600. PubMed ID: 16554754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of bone marrow beta3-integrin enhances non-functional neovascularization.
    Watson AR; Pitchford SC; Reynolds LE; Direkze N; Brittan M; Alison MR; Rankin S; Wright NA; Hodivala-Dilke KM
    J Pathol; 2010 Mar; 220(4):435-45. PubMed ID: 19967726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.
    Kirsammer G; Jilani S; Liu H; Davis E; Gurbuxani S; Le Beau MM; Crispino JD
    Blood; 2008 Jan; 111(2):767-75. PubMed ID: 17901249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessary for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndrome.
    Duchon A; Pothion S; Brault V; Sharp AJ; Tybulewicz VL; Fisher EM; Herault Y
    Behav Brain Res; 2011 Mar; 217(2):271-81. PubMed ID: 21047530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosage of the Abcg1-U2af1 region modifies locomotor and cognitive deficits observed in the Tc1 mouse model of Down syndrome.
    Marechal D; Lopes Pereira P; Duchon A; Herault Y
    PLoS One; 2015; 10(2):e0115302. PubMed ID: 25706610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.
    Ng AP; Hu Y; Metcalf D; Hyland CD; Ierino H; Phipson B; Wu D; Baldwin TM; Kauppi M; Kiu H; Di Rago L; Hilton DJ; Smyth GK; Alexander WS
    PLoS Genet; 2015 May; 11(5):e1005211. PubMed ID: 25973911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome.
    De Vita S; Canzonetta C; Mulligan C; Delom F; Groet J; Baldo C; Vanes L; Dagna-Bricarelli F; Hoischen A; Veltman J; Fisher EM; Tybulewicz VL; Nizetic D
    Oncogene; 2010 Nov; 29(46):6102-14. PubMed ID: 20697343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.